Researchers at Lund University in Sweden have invented a protein capable of working on the body’s immune system. This can also be used to provide very long-term survival for cancer patients affected by autoimmune diseases. Donning a sarcoma is a major problem, as the immune system and sufficient amounts of white blood cells (leukocytes) are generally destroyed during surgery.
Sarcoma diagnoses.
During an autoimmune autoimmune disease, parts of the immune system become cancerous. Beside the symptoms which may include fatigue and tension, there may also follow symptoms such as difficulty breathing and memory loss. It takes some time for long-term survival to be achieved.
Over decades, it has been established that the immune system on the surface of the body contributes significantly to this (but the role of the immune cells in cancer treatment has not been studied in detail). In fact, a lot of research has focused on the impact of various biological factors on immune cells. But recently, with the help of a Capex-based same-cell fusion technology, it has been recognized that the effects of the immune system are also a major factor in the treatment of cancer.
Capexed, a modular flexible gel chip platform, showed its viability after 24 hours. This is made possible with the Capexer gel chip, an artificial cell fusion chip.
ElcoRegenerator -a regenerator-a generator-a chip-a computer chip-computer chip.
In its personalized mechanism, the research team has incorporated a network of computational processes. Moreover, the collaboration with Lund company Aegis has significantly improved the speed of the process at the cellular level, contributing to almost 50% of the results.
Structural and biochemical distances.
Current solutions focus on individual cells. But the results of the research team, which is especially grateful to the collaboration with Lund, show structural and biochemical distances for the process at a molecular level. This, in turn, improved the interaction at the cellular level.
Studies on the matrix and organ-on-chip.
In addition, these results have brilliantly led to results which can play a positive role in the management of cancer, and therefore, in the field of health.
As result, we have shown the potential uses of collagen and elastomerase for the treatment of physio-surgical injuries and other types of serious medical conditions, i.e. sarcoma, endometritis and myeloid conditions.